Search Results
Results found for "Norton Cheng"
- GPCR Happy Hour – Boston, Sept 2025
America, NIS delivers cutting-edge imaging and analysis that accelerates the discovery of new and life-changing
- G protein-biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease..
The changes in amyloid pathology are accompanied by robust microglial and astrocytic hypertrophy, which
- Phospholipid Scrambling by G Protein-Coupled Receptors
Conformational changes that facilitate scrambling are distinct from those associated with GPCR signaling
- Canonical chemokine receptors as scavenging “decoys”
2000), becoming incapable of promoting cell migration, a phenomenon which is likely to be mediated by changes
- How Fast Does a Drug Work?
Competitive conditions —such as the presence of endogenous ligands— change kinetic behavior , and ignoring
- Radioligands vs. Fluorescent Ligands: Binding Assays
with a higher specific activity, but a shorter half-life (60 days), which complicates storage, besides changing
- GPCRs Are Optimal Regulators of Complex Biological Systems and Orchestrate the Interface between ...
molecular diversity of GPCR signaling systems is likely to be closely associated with disease-associated changes
- Integrated GPCR Drug Discovery: A Structured Framework for Modern Programs
Why this matters: Membrane context changes signaling outcomes.
- Early Safety Assays: Identifying Showstoppers in GPCR Drug Discovery Pipelines Early
/no-go choices Strategic insights into early identification and mitigation of drug liabilities Game-Changing
- G protein-coupled receptor interactions and modification of signalling involving the ghrelin ...
In all cases, the receptor interaction changes downstream signalling and the responses to receptor agonists
- How Schild Analysis Protects Your Conclusions in GPCR Research
Anyone who joins before the change is fully grandfathered — your rate stays locked, and your whole team
- Structural dynamics of Smoothened (SMO) in ciliary membrane and its interaction with membrane lipids
Structural analysis of SMO domains shows significant changes in the CRD and ICD, during the course of
- Irreversible Drugs, Real Control: Design for Durable Target Engagement
Target Engagement—Don’t Chase It with Irreversible Drugs When binding outlives exposure, everything changes
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
. 🎧 Go behind the scenes with Revvity —from the chemistry to the critical moments that changed everything
- Fluorescence Polarization in GPCR Research
Adapted from: Zhang Y, Tang H, Chen W, Zhang J. is most effective at studying interactions between large proteins and small ligands thanks to this change
- Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?
Every time a problem arises, we trace it back to its root cause, implementing changes that prevent its
- Why Mastering Pharmacokinetics Fundamentals Still Defines Discovery Success Today
Crucially, altering one does not inherently change the others—a principle often overlooked in early discovery
- Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor
Here, we investigate the conformational changes induced by the binding of a nanobody (Nb80) on the active-like
- When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue
Seeing that probe expose receptor distribution across an entire native islet changed what they believed
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
This paper thoroughly investigated the role of single amino acid changes to clarify the molecular mechanisms
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
clarity—so you can pick better targets, stress-test hypotheses earlier, and focus on experiments that change
- The Five Traps of Ignoring Kinetics
That’s where Terry’s Corner changes the game.
- When January Looks Different by March: Orthosteric vs. Allosteric Insights from Our Latest AMA
Demonstrating changes in association or dissociation rates moves analysis beyond functional shifts toward
- How Collaboration Drives GPCR Discoveries
That changed when JB’s team walked in with a different lens.
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
Guo, W., et al., Crosstalk in G protein-coupled receptors: Changes at the transmembrane homodimer interface
- 📰 GPCR Weekly News, April 1 to 7, 2024
Farma Reports Its 2023 Annual Financial Resultsand Confirms Its 2024 Outlook Sosei Heptares officially changed
- From Lab Logic to Leadership: How Scientific Thinking Holds Back Biotech Operations
And that difference changes everything. 👉 Scientific thinking values thoroughness, error reduction,
- A Note from Yamina: Building the Next Chapter of Dr. GPCR
Anyone who joins Premium before these changes go live will be grandfathered at their current rate , as
- 📰 GPCR Weekly News, March 4 to 10, 2024
from March 4th to 10th, 2024 GPCR Activation and Signaling Glu1022.53-Mediated Early Conformational Changes
- Understanding Enzyme Inhibition In GPCR Discovery Programs
Why micro-domains change what “global” signaling can and can’t explain.




















